RIVIVE (NALOXONE HYDROCHLORIDE) — FDA Approval NDA217722 (HARM REDUCTION THERP)
RIVIVE (NALOXONE HYDROCHLORIDE) — FDA Approval NDA217722 (HARM REDUCTION THERP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RIVIVE; Active ingredients: NALOXONE HYDROCHLORIDE; Application number: NDA217722.
| Brand name | RIVIVE |
|---|---|
| Active ingredients | NALOXONE HYDROCHLORIDE |
| Application number | NDA217722 |
| Sponsor | HARM REDUCTION THERP |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Marketing status | Over-the-counter |
| Products in application | 1 |
| First approval date | 20230728 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →